April 24 – 26 2017

Boston, USA

 

Brammer Bio

brammer bio

Brammer Bio: Exhibitor

Brammer Bio is a CDMO focused on providing process development, clinical, and commercial supply of cell and gene therapy products, enabling the delivery of novel medicines and improving patient health. We have a highly skilled team with the development, manufacturing, analytical, and operational expertise from over 100 client projects that is required to tackle the challenges posed by these novel technologies. We can accelerate your product transition from the clinic to patients while focusing on meeting cGMP standards and commercial expectations. Brammer Bio has the expertise to support your gene and cell therapy projects to Phase III, commercial approval, and beyond.